In addition, COL18A1 has been proved to be a promising biomarker for ovarian cancer and was possibly involved in the progression of bladder cancer (Fang et al., 2013; Peters et al., 2005). The gene discussed is COL18A1; the disease is urinary bladder carcinoma.